Richard C Evans

Title: Richard C. Evans: Innovator in Pharmaceutical Compositions

Introduction

Richard C. Evans is an inventive mind based in Carey, North Carolina, known for his contributions to the field of pharmaceutical compositions. With a focus on enhancing mucociliary clearance, he has developed innovative solutions to address significant health challenges.

Latest Patents

Richard C. Evans holds a patent for a pharmaceutical composition of uridine 5'-triphosphate (UTP). This novel formulation is designed to promote increased mucociliary clearance of retained mucus secretions in the human airways, middle/inner ears, or sinuses. The patent describes two formulations: Formulation I, which comprises UTP in an aqueous solution with a therapeutic concentration between 5 and 45 mg/mL, and Formulation II, which holds UTP close to its solubility limit for effective delivery through portable inhalation devices. These formulations boast extended shelf lives and offer therapeutic benefits in a compact delivery system.

Career Highlights

Richard is associated with Inspire Pharmaceuticals, Inc., where he has been pivotal in advancing pharmaceutical innovation. His patent reflects a deep understanding of biochemistry and a commitment to improving patient outcomes through effective medication delivery.

Collaborations

Throughout his career, Richard C. Evans has collaborated with esteemed colleagues such as Karol K. LaCroix and Christy L. Shaffer. These partnerships exemplify his ability to work within a team of talented professionals to push the boundaries of pharmaceutical development.

Conclusion

Richard C. Evans stands out as a significant inventor in the pharmaceutical industry, contributing to advancements that enhance patient care. His patented formulations of uridine triphosphate exemplify the innovative spirit necessary for addressing modern medical challenges, showcasing the role of inventors in driving progress within the healthcare sector.